Corvex (MOVE) versus Its Rivals Head to Head Review

Corvex (NASDAQ:MOVE – Get Free Report) is one of 271 publicly-traded companies in the “IT Services” industry, but how does it contrast to its rivals? We will compare Corvex to related businesses based on the strength of its risk, dividends, earnings, valuation, institutional ownership, analyst recommendations and profitability.

Insider and Institutional Ownership

16.6% of Corvex shares are held by institutional investors. Comparatively, 36.7% of shares of all “IT Services” companies are held by institutional investors. 23.7% of Corvex shares are held by company insiders. Comparatively, 20.4% of shares of all “IT Services” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings and Valuation

This table compares Corvex and its rivals gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Corvex $430,000.00 -$18.28 million -0.27
Corvex Competitors $3.24 billion $227.67 million -24.02

Corvex’s rivals have higher revenue and earnings than Corvex. Corvex is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Risk and Volatility

Corvex has a beta of 0.92, meaning that its stock price is 8% less volatile than the S&P 500. Comparatively, Corvex’s rivals have a beta of 2.15, meaning that their average stock price is 115% more volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Corvex and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Corvex 1 1 1 0 2.00
Corvex Competitors 1992 5654 9471 342 2.47

Corvex currently has a consensus target price of $18.75, indicating a potential upside of 274.25%. As a group, “IT Services” companies have a potential upside of 30.17%. Given Corvex’s higher probable upside, research analysts clearly believe Corvex is more favorable than its rivals.

Profitability

This table compares Corvex and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Corvex -624.33% N/A -9.12%
Corvex Competitors -191.23% -32.13% -8.65%

Summary

Corvex rivals beat Corvex on 9 of the 13 factors compared.

About Corvex

(Get Free Report)

Movano Inc. engages in developing a platform to deliver healthcare solutions at the intersection of medical and consumer devices. The company is involved in the development of Evie Ring, which is a wearable designed specifically for women that combines health and wellness metrics comprises resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, and menstrual symptom tracking, as well as activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. It develops System-on-a-Chip (SoC) for blood pressure or continuous glucose monitoring (CGM) systems. The company was formerly known as Maestro Sensors Inc. and changed its name to Movano Inc. in August 2018. Movano Inc. was incorporated in 2018 and is based in Pleasanton, California.

Receive News & Ratings for Corvex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corvex and related companies with MarketBeat.com's FREE daily email newsletter.